Engaging Men Through HIV Self-Testing With Differentiated Care to Improve ART Initiation and Viral Suppression Among Men in Malawi
NCT ID: NCT04858243
Last Updated: 2023-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
930 participants
INTERVENTIONAL
2021-08-02
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Innovative Strategies to Increase ART Initiation and Viral Suppression Among HIV-positive Men in Malawi
NCT04878601
Identifying Efficient Linkage Strategies for Men
NCT05137210
Assessing Strategies for Increasing Male Involvement in Malawi's Antenatal Program
NCT02139176
Bringing South African Men Into HIV Counseling and Testing and Care
NCT03794245
Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners
NCT03271307
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Facility-Based ART (fbART arm): community-based male-specific counseling followed by linkage to a local health facility for ART initiation and continuation.
Home-Based ART (hbART arm): community-based male-specific counseling followed by home-based ART initiation (or at any location that is convenient for participants) and home-based ART continuation for a 3-month period, followed by linkage to a local health facility for further ART continuation.
Objective: Our primary objective is to compare the impact of home-based ART against standard of care for ART initiation and retention among men identified as HIV-positive through HIVST in Malawi. Our specific Aims are:
Aim 1. Test the effectiveness of hbART versus fbART on ART initiation and 6-month viral suppression among men living with HIV.
Aim 2. Identify predictors of ART initiation and 6-month viral suppression in the hbART arm
Aim 3. Determine the cost-effectiveness and scalability of hbART at a national level.
Methods: We will perform an individually randomized control trial with 820 HIV-positive men who have not yet initiated ART and a subset of 110 of their female partners. Men will be individually randomized 1:1 to one of the two intervention arms described above and will be enrolled in the study for 18-months or until 12-month retention (secondary outcome) can be measured, whichever comes first. The study will be performed at 10 health facilities supported by Partners in Hope (PIH). Data collection will include baseline and follow-up surveys at 2-, 4-, and 7-months, as well as medical charter reviews for men at 2-, 4-, 7-, and 13-months after study enrollment. Qualitative interviews will be conducted with a subset of men and women to understand perceptions of the intervention and experiences with ART engagement, and cost data from a provider perspective will be collected for a cost analysis of each arm.
Anticipated results: Findings will establish the effectiveness of home-based ART among men living with HIV who have not yet engaged in treatment, and can directly inform HIV programs throughout the region. Findings will also help us assess if short-term home-based ART is sufficient to engage men in long-term facility-based care, or if additional, more resource-intensive services are needed, such as major changes to the structure of facility-based ART.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Facility-Based ART
Men escorted to nearest health facility for ART initiation and continuation.
Facility-Based ART
Community-based male-specific counseling followed by linkage to a local health facility for ART initiation and continuation.
Home-Based ART
Home-based ART initiation and continuation provided for 3-months.
Home-Based ART
Community-based male-specific counseling followed by home-based ART initiation (or at any location that is convenient for participants) and home-based ART continuation for a 3-month period, followed by linkage to a local health facility for further ART continuation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home-Based ART
Community-based male-specific counseling followed by home-based ART initiation (or at any location that is convenient for participants) and home-based ART continuation for a 3-month period, followed by linkage to a local health facility for further ART continuation.
Facility-Based ART
Community-based male-specific counseling followed by linkage to a local health facility for ART initiation and continuation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No reported interpersonal violence (IPV) as defined by World Health Organization (WHO) with the above male partner in the past 12-months
* Male partner ever tested HIV-positive
* Male partner not currently engaged in ART services, defined as:
* Tested HIV-positive ≥14 days and not on ART ≥14 days after testing HIV- positive;
* ≥14 days late for the first four-week follow up appointment; or
* Initiated ART but ≥60 days late for last ART appointment;
* Male partner living inside the facility catchment area (defined as any area that Healthcare Workers (HCWs) from the study facility routinely visit for tracing purposes)
* ≥15 years of age
* Tested HIV positive using Ministry of Health standard algorithm (Determine + Unigold)
* Not currently engaged in ART services, defined as:
* Tested HIV-positive ≥14 days and not on ART ≥14 days after testing HIV-positive;
* ≥14 days late for the first four-week follow up appointment; or
* Initiated ART but ≥60 days late for last ART appointment;
* Has not taken ART in the past 7-days, as indicated by a point of care (POC) urine assay
* Living inside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes)
Exclusion Criteria
* Reported interpersonal violence (IPV) as defined by WHO with the above male partner in the past 12-months
* Male partner never tested HIV positive
* Male partner tested HIV-positive \<14 days ago
* Male partner currently engaged in ART services, defined as:
* Initiated ART \<14 days late for the first four-week follow up appointment
* Initiated ART and \<60 days late for last ART appointment
* Male partner living outside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes)
* \<15 years of age
* Never tested HIV positive using Ministry of Health standard algorithm (Determine + Unigold)
* Tested HIV-positive \<14 days ago
* Currently engaged in ART services, defined as:
* Initiated ART
* \<14 days late for the first four-week follow up appointment
* Initiated ART and \<60 days late for last ART appointment
* Has taken ART in the past 7-days, as indicated by a point of care (POC) urine assay
* Living outside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes)
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Partners in Hope, Inc.
INDUSTRY
Medical University of South Carolina
OTHER
Charles University, Czech Republic
OTHER
University of Cape Town
OTHER
National Institute of Mental Health (NIMH)
NIH
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas J. Coates
Director of University of California Global Health Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Partners in Hope
Lilongwe, , Malawi
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hubbard J, Mphande M, Robson I, Balakasi K, Phiri K, Chikuse E, Thorp M, Phiri S, Choko AT, Cornell M, Coates T, Dovel K. Core components of male-specific person-centred HIV care: a qualitative analysis from client and healthcare worker perspectives in Malawi. BMJ Public Health. 2024 Dec 22;2(2):e001100. doi: 10.1136/bmjph-2024-001100. eCollection 2024 Dec.
Holland KN, Hubbard J, Mphande M, Robson I, Phiri K, Onoya D, Chikuse E, Dovel K, Choko A. Implementation of Male-Specific Motivational Interviewing in Malawi: An Assessment of Intervention Fidelity and Barriers to Scale-Up. medRxiv [Preprint]. 2024 Sep 26:2024.09.24.24314326. doi: 10.1101/2024.09.24.24314326.
Choko AT, Coates TJ, Mphande M, Balakasi K, Robson I, Phiri K, Phiri S, Kulich M, Sweat M, Cornell M, Hoffman RM, Dovel K. Engaging men through HIV self-testing with differentiated care to improve ART initiation and viral suppression among men in Malawi (ENGAGE): A study protocol for a randomized control trial. PLoS One. 2023 Feb 24;18(2):e0281472. doi: 10.1371/journal.pone.0281472. eCollection 2023.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.